FDA: Medtronic Brain Stimulator Missed Study Goal

Posted by admin on September 28th, 2011

U.S. Stocks Erase Gains Amid Concern Over Chinese Inflation
March 10 (Bloomberg) -- U.S. stocks erased gains as the Standard & Poor’s 500 Index approached its high of the year for a second day and speculation grew that accelerating inflation will force China to raise interest rates.

Read more on Bloomberg

FDA: Medtronic Brain Stimulator Missed Study Goal
FDA says Medtronic's nerve stimulating brain implant failed to reduce seizures Medtronic - Food and Drug Administration - Health - Conditions and Diseases - Neurological Disorders

Read more on ABC News

No related content found.

Did you like this? Share it:

Tags: Abc News, Bloomberg, brain, Brain Implant, Brain Stimulator, China, Diseases, Fda, Food And Drug, Food And Drug Administration, Goal, Health Conditions And Diseases Neurological Disorders, Inflation, Interest Rates, Medtronic, Missed, Nerve, S 500, Seizures, Speculation, Stimulator, stocks, Study, Study Goal

Posted in Depression News

You can leave a response, or trackback from your own site.

One Response to “FDA: Medtronic Brain Stimulator Missed Study Goal”

albo888888 says:

July 29, 2011 at 7:06 am

Moderate long term interest rates help control the inflationary gap, making the economy more stable.

Reply

Leave a Reply